Is there a clinical difference in outcomes when beta-agonist therapy is delivered through metered-dose inhaler (MDI) with a spacing device compared with standard nebulizer treatments in acutely wheezing children?
Stephens
M B
MB
Uniformed Services, University of the Health Sciences, Bethesda, Maryland, USA. Mstephens@usuhs.mil
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000494:pharmacology; D000420:Albuterol / Q000008:administration & dosage* / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy*; D002675:Child, Preschool; D004311:Double-Blind Method; D006801:Humans; D007223:Infant; D009330:Nebulizers and Vaporizers; D015656:Respiratory Mechanics / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000420:Albuterol